Cargando…

Changes in life expectancy and disease burden in Norway, 1990–2019: an analysis of the Global Burden of Disease Study 2019

BACKGROUND: Geographical differences in health outcomes are reported in many countries. Norway has led an active policy aiming for regional balance since the 1970s. Using data from the Global Burden of Disease Study (GBD) 2019, we examined regional differences in development and current state of hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Clarsen, Benjamin, Nylenna, Magne, Klitkou, Søren Toksvig, Vollset, Stein Emil, Baravelli, Carl Michael, Bølling, Anette Kocbach, Aasvang, Gunn Marit, Sulo, Gerhard, Naghavi, Mohsen, Pasovic, Maja, Asaduzzaman, Muhammad, Bjørge, Tone, Eggen, Anne Elise, Eikemo, Terje Andreas, Ellingsen, Christian Lycke, Haaland, Øystein Ariansen, Hailu, Alemayehu, Hassan, Shoaib, Hay, Simon I, Juliusson, Petur B, Kisa, Adnan, Kisa, Sezer, Månsson, Johan, Mekonnen, Teferi, Murray, Christopher J L, Norheim, Ole F, Ottersen, Trygve, Sagoe, Dominic, Sripada, Kam, Winkler, Andrea Sylvia, Knudsen, Ann Kristin Skrindo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier, Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253891/
https://www.ncbi.nlm.nih.gov/pubmed/35779543
http://dx.doi.org/10.1016/S2468-2667(22)00092-5
_version_ 1784740589559873536
author Clarsen, Benjamin
Nylenna, Magne
Klitkou, Søren Toksvig
Vollset, Stein Emil
Baravelli, Carl Michael
Bølling, Anette Kocbach
Aasvang, Gunn Marit
Sulo, Gerhard
Naghavi, Mohsen
Pasovic, Maja
Asaduzzaman, Muhammad
Bjørge, Tone
Eggen, Anne Elise
Eikemo, Terje Andreas
Ellingsen, Christian Lycke
Haaland, Øystein Ariansen
Hailu, Alemayehu
Hassan, Shoaib
Hay, Simon I
Juliusson, Petur B
Kisa, Adnan
Kisa, Sezer
Månsson, Johan
Mekonnen, Teferi
Murray, Christopher J L
Norheim, Ole F
Ottersen, Trygve
Sagoe, Dominic
Sripada, Kam
Winkler, Andrea Sylvia
Knudsen, Ann Kristin Skrindo
author_facet Clarsen, Benjamin
Nylenna, Magne
Klitkou, Søren Toksvig
Vollset, Stein Emil
Baravelli, Carl Michael
Bølling, Anette Kocbach
Aasvang, Gunn Marit
Sulo, Gerhard
Naghavi, Mohsen
Pasovic, Maja
Asaduzzaman, Muhammad
Bjørge, Tone
Eggen, Anne Elise
Eikemo, Terje Andreas
Ellingsen, Christian Lycke
Haaland, Øystein Ariansen
Hailu, Alemayehu
Hassan, Shoaib
Hay, Simon I
Juliusson, Petur B
Kisa, Adnan
Kisa, Sezer
Månsson, Johan
Mekonnen, Teferi
Murray, Christopher J L
Norheim, Ole F
Ottersen, Trygve
Sagoe, Dominic
Sripada, Kam
Winkler, Andrea Sylvia
Knudsen, Ann Kristin Skrindo
author_sort Clarsen, Benjamin
collection PubMed
description BACKGROUND: Geographical differences in health outcomes are reported in many countries. Norway has led an active policy aiming for regional balance since the 1970s. Using data from the Global Burden of Disease Study (GBD) 2019, we examined regional differences in development and current state of health across Norwegian counties. METHODS: Data for life expectancy, healthy life expectancy (HALE), years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) in Norway and its 11 counties from 1990 to 2019 were extracted from GBD 2019. County-specific contributors to changes in life expectancy were compared. Inequality in disease burden was examined by use of the Gini coefficient. FINDINGS: Life expectancy and HALE improved in all Norwegian counties from 1990 to 2019. Improvements in life expectancy and HALE were greatest in the two counties with the lowest values in 1990: Oslo, in which life expectancy and HALE increased from 71·9 years (95% uncertainty interval 71·4–72·4) and 63·0 years (60·5–65·4) in 1990 to 81·3 years (80·0–82·7) and 70·6 years (67·4–73·6) in 2019, respectively; and Troms og Finnmark, in which life expectancy and HALE increased from 71·9 years (71·5–72·4) and 63·5 years (60·9–65·6) in 1990 to 80·3 years (79·4–81·2) and 70·0 years (66·8–72·2) in 2019, respectively. Increased life expectancy was mainly due to reductions in cardiovascular disease, neoplasms, and respiratory infections. No significant differences between the national YLD or DALY rates and the corresponding age-standardised rates were reported in any of the counties in 2019; however, Troms og Finnmark had a higher age-standardised YLL rate than the national rate (8394 per 100 000 [95% UI 7801–8944] vs 7536 per 100 000 [7391–7691]). Low inequality between counties was shown for life expectancy, HALE, all level-1 causes of DALYs, and exposure to level-1 risk factors. INTERPRETATION: Over the past 30 years, Norway has reduced inequality in disease burden between counties. However, inequalities still exist at a within-county level and along other sociodemographic gradients. Because of insufficient Norwegian primary data, there remains substantial uncertainty associated with regional estimates for non-fatal disease burden and exposure to risk factors. FUNDING: Bill & Melinda Gates Foundation, Research Council of Norway, and Norwegian Institute of Public Health.
format Online
Article
Text
id pubmed-9253891
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier, Ltd
record_format MEDLINE/PubMed
spelling pubmed-92538912022-07-08 Changes in life expectancy and disease burden in Norway, 1990–2019: an analysis of the Global Burden of Disease Study 2019 Clarsen, Benjamin Nylenna, Magne Klitkou, Søren Toksvig Vollset, Stein Emil Baravelli, Carl Michael Bølling, Anette Kocbach Aasvang, Gunn Marit Sulo, Gerhard Naghavi, Mohsen Pasovic, Maja Asaduzzaman, Muhammad Bjørge, Tone Eggen, Anne Elise Eikemo, Terje Andreas Ellingsen, Christian Lycke Haaland, Øystein Ariansen Hailu, Alemayehu Hassan, Shoaib Hay, Simon I Juliusson, Petur B Kisa, Adnan Kisa, Sezer Månsson, Johan Mekonnen, Teferi Murray, Christopher J L Norheim, Ole F Ottersen, Trygve Sagoe, Dominic Sripada, Kam Winkler, Andrea Sylvia Knudsen, Ann Kristin Skrindo Lancet Public Health Articles BACKGROUND: Geographical differences in health outcomes are reported in many countries. Norway has led an active policy aiming for regional balance since the 1970s. Using data from the Global Burden of Disease Study (GBD) 2019, we examined regional differences in development and current state of health across Norwegian counties. METHODS: Data for life expectancy, healthy life expectancy (HALE), years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) in Norway and its 11 counties from 1990 to 2019 were extracted from GBD 2019. County-specific contributors to changes in life expectancy were compared. Inequality in disease burden was examined by use of the Gini coefficient. FINDINGS: Life expectancy and HALE improved in all Norwegian counties from 1990 to 2019. Improvements in life expectancy and HALE were greatest in the two counties with the lowest values in 1990: Oslo, in which life expectancy and HALE increased from 71·9 years (95% uncertainty interval 71·4–72·4) and 63·0 years (60·5–65·4) in 1990 to 81·3 years (80·0–82·7) and 70·6 years (67·4–73·6) in 2019, respectively; and Troms og Finnmark, in which life expectancy and HALE increased from 71·9 years (71·5–72·4) and 63·5 years (60·9–65·6) in 1990 to 80·3 years (79·4–81·2) and 70·0 years (66·8–72·2) in 2019, respectively. Increased life expectancy was mainly due to reductions in cardiovascular disease, neoplasms, and respiratory infections. No significant differences between the national YLD or DALY rates and the corresponding age-standardised rates were reported in any of the counties in 2019; however, Troms og Finnmark had a higher age-standardised YLL rate than the national rate (8394 per 100 000 [95% UI 7801–8944] vs 7536 per 100 000 [7391–7691]). Low inequality between counties was shown for life expectancy, HALE, all level-1 causes of DALYs, and exposure to level-1 risk factors. INTERPRETATION: Over the past 30 years, Norway has reduced inequality in disease burden between counties. However, inequalities still exist at a within-county level and along other sociodemographic gradients. Because of insufficient Norwegian primary data, there remains substantial uncertainty associated with regional estimates for non-fatal disease burden and exposure to risk factors. FUNDING: Bill & Melinda Gates Foundation, Research Council of Norway, and Norwegian Institute of Public Health. Elsevier, Ltd 2022-06-29 /pmc/articles/PMC9253891/ /pubmed/35779543 http://dx.doi.org/10.1016/S2468-2667(22)00092-5 Text en © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Articles
Clarsen, Benjamin
Nylenna, Magne
Klitkou, Søren Toksvig
Vollset, Stein Emil
Baravelli, Carl Michael
Bølling, Anette Kocbach
Aasvang, Gunn Marit
Sulo, Gerhard
Naghavi, Mohsen
Pasovic, Maja
Asaduzzaman, Muhammad
Bjørge, Tone
Eggen, Anne Elise
Eikemo, Terje Andreas
Ellingsen, Christian Lycke
Haaland, Øystein Ariansen
Hailu, Alemayehu
Hassan, Shoaib
Hay, Simon I
Juliusson, Petur B
Kisa, Adnan
Kisa, Sezer
Månsson, Johan
Mekonnen, Teferi
Murray, Christopher J L
Norheim, Ole F
Ottersen, Trygve
Sagoe, Dominic
Sripada, Kam
Winkler, Andrea Sylvia
Knudsen, Ann Kristin Skrindo
Changes in life expectancy and disease burden in Norway, 1990–2019: an analysis of the Global Burden of Disease Study 2019
title Changes in life expectancy and disease burden in Norway, 1990–2019: an analysis of the Global Burden of Disease Study 2019
title_full Changes in life expectancy and disease burden in Norway, 1990–2019: an analysis of the Global Burden of Disease Study 2019
title_fullStr Changes in life expectancy and disease burden in Norway, 1990–2019: an analysis of the Global Burden of Disease Study 2019
title_full_unstemmed Changes in life expectancy and disease burden in Norway, 1990–2019: an analysis of the Global Burden of Disease Study 2019
title_short Changes in life expectancy and disease burden in Norway, 1990–2019: an analysis of the Global Burden of Disease Study 2019
title_sort changes in life expectancy and disease burden in norway, 1990–2019: an analysis of the global burden of disease study 2019
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253891/
https://www.ncbi.nlm.nih.gov/pubmed/35779543
http://dx.doi.org/10.1016/S2468-2667(22)00092-5
work_keys_str_mv AT clarsenbenjamin changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT nylennamagne changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT klitkousørentoksvig changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT vollsetsteinemil changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT baravellicarlmichael changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT bøllinganettekocbach changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT aasvanggunnmarit changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT sulogerhard changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT naghavimohsen changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT pasovicmaja changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT asaduzzamanmuhammad changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT bjørgetone changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT eggenanneelise changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT eikemoterjeandreas changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT ellingsenchristianlycke changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT haalandøysteinariansen changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT hailualemayehu changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT hassanshoaib changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT haysimoni changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT juliussonpeturb changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT kisaadnan changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT kisasezer changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT manssonjohan changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT mekonnenteferi changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT murraychristopherjl changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT norheimolef changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT ottersentrygve changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT sagoedominic changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT sripadakam changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT winklerandreasylvia changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019
AT knudsenannkristinskrindo changesinlifeexpectancyanddiseaseburdeninnorway19902019ananalysisoftheglobalburdenofdiseasestudy2019